Health
Horizon Discovery licenses CHOSOURCE to Sanyou Biopharmaceuticals Co. – News-Medical.net
Horizon Discovery today announced that it has granted commercial licenses for its cGMP-compliant CHOSOURCE™ platform to Sanyou Biopharmaceuticals.
Horizon Discovery Group plc, a global leader in the application of gene editing and gene modulation for cell line engineering, today announced that it has granted two commercial licenses for its cGMP-compliant CHOSOURCE™ platform to Sanyou Biopharmaceuticals Co., Ltd., a leading biotechnology company focused on research, development and providing integrated solutions for innovative antibody drug developments.
Sanyou will use Horizon’s gene-edited Glutamine Synthetase (GS) knockout Chinese Hamster…
-
General16 hours agoCollingwood cult hero Mason Cox not offered new contract for 2026 AFL season
-
Noosa News24 hours agoSouth East Queensland on alert as ‘right mix of ingredients’ could trigger severe storm outbreak
-
Noosa News22 hours agoHeavy horsemen keep farming traditions alive
-
Noosa News19 hours agoSevere thunderstorms, damaging winds and large hail forecast for Saturday evening